Global Longitudinal Strain : Is It Time to Change the Preoperative Cardiac Assessment of Oncology Patients?
The introduction of new anticancer treatment modalities has improved survival rates, transforming cancer into a chronic disease in many instances. One of the most devastating complications of cancer treatment is cancer therapy-related cardiac dysfunction. Adequate preoperative assessment of any significant cancer therapy-related cardiac impairment is critical, and may be missed with conventional measures. The assessment of global longitudinal strain by speckle-tracking echocardiography is more sensitive for the early detection of cardiac contractility before a decline in ejection fraction can be discovered. Global longitudinal strain can also predict postoperative cardiac dysfunction, which makes it a good alternative for preoperative cardiac assessment in the oncology population when cancer therapies have been administered that can alter normal performance.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Oncology and therapy - 9(2021), 1 vom: 29. Juni, Seite 13-19 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shehata, Islam Mohammad [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 04.06.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s40487-020-00134-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318159503 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318159503 | ||
| 003 | DE-627 | ||
| 005 | 20231225164755.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40487-020-00134-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1060.xml |
| 035 | |a (DE-627)NLM318159503 | ||
| 035 | |a (NLM)33249544 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shehata, Islam Mohammad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Global Longitudinal Strain |b Is It Time to Change the Preoperative Cardiac Assessment of Oncology Patients? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 04.06.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a The introduction of new anticancer treatment modalities has improved survival rates, transforming cancer into a chronic disease in many instances. One of the most devastating complications of cancer treatment is cancer therapy-related cardiac dysfunction. Adequate preoperative assessment of any significant cancer therapy-related cardiac impairment is critical, and may be missed with conventional measures. The assessment of global longitudinal strain by speckle-tracking echocardiography is more sensitive for the early detection of cardiac contractility before a decline in ejection fraction can be discovered. Global longitudinal strain can also predict postoperative cardiac dysfunction, which makes it a good alternative for preoperative cardiac assessment in the oncology population when cancer therapies have been administered that can alter normal performance | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cancer therapy-related cardiac dysfunction | |
| 650 | 4 | |a Cardiac dysfunction | |
| 650 | 4 | |a Global longitudinal strain | |
| 650 | 4 | |a Heart failure | |
| 650 | 4 | |a Left ventricular ejection fraction | |
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Preoperative cardiac assessment | |
| 650 | 4 | |a Speckle-tracking echocardiography | |
| 700 | 1 | |a Odell, Tiffany D |e verfasserin |4 aut | |
| 700 | 1 | |a Elhassan, Amir |e verfasserin |4 aut | |
| 700 | 1 | |a Urits, Ivan |e verfasserin |4 aut | |
| 700 | 1 | |a Viswanath, Omar |e verfasserin |4 aut | |
| 700 | 1 | |a Kaye, Alan D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncology and therapy |d 2016 |g 9(2021), 1 vom: 29. Juni, Seite 13-19 |w (DE-627)NLM269530347 |x 2366-1089 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2021 |g number:1 |g day:29 |g month:06 |g pages:13-19 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40487-020-00134-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2021 |e 1 |b 29 |c 06 |h 13-19 | ||